HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaofeng Zeng Selected Research

Immunosuppressive Agents (Immunosuppressants)

9/2022Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
4/2022Research progress of BK virus and systemic lupus erythematosus.
11/2021Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
1/2021Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections.
12/2020Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
1/2019Pituitary Involvement in Granulomatosis with Polyangiitis: A Retrospective Analysis in a Single Chinese Hospital and a Literature Review.
10/2018Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
1/2018Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.
1/2017Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE.
12/2015Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaofeng Zeng Research Topics

Disease

43Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 12/2009
24Immunoglobulin G4-Related Disease
01/2022 - 05/2014
14Pulmonary Arterial Hypertension
11/2022 - 08/2013
12Autoimmune Diseases (Autoimmune Disease)
11/2022 - 12/2009
12Thrombocytopenia (Thrombopenia)
06/2022 - 09/2011
11Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 01/2014
11Arthritis (Polyarthritis)
10/2021 - 09/2010
11Infections
01/2021 - 01/2013
10Dermatomyositis (Dermatopolymyositis)
03/2021 - 11/2014
10Inflammation (Inflammations)
12/2020 - 12/2009
9Connective Tissue Diseases (Connective Tissue Disease)
11/2022 - 01/2015
8Ankylosing Spondylitis
11/2022 - 01/2019
8Takayasu Arteritis (Arteritis, Takayasu's)
12/2021 - 12/2016
7Neoplasms (Cancer)
11/2022 - 12/2016
7Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 01/2018
7Rheumatoid Arthritis
10/2022 - 06/2002
7Systemic Scleroderma (Systemic Sclerosis)
11/2021 - 01/2013
6Myositis (Idiopathic Inflammatory Myopathies)
11/2021 - 01/2019
6Pain (Aches)
05/2021 - 12/2015
5Rheumatic Diseases (Rheumatism)
12/2021 - 07/2003
5Hypersensitivity (Allergy)
07/2021 - 12/2015
4Body Weight (Weight, Body)
05/2022 - 12/2009
4Fever (Fevers)
01/2022 - 09/2010
4Lupus Nephritis
01/2020 - 12/2009
4Exanthema (Rash)
10/2019 - 09/2010
3Neuroblastoma
05/2022 - 01/2018
3Diarrhea
01/2022 - 12/2015
3Vasculitis (Vasculitides)
01/2022 - 01/2020
3Thrombosis (Thrombus)
01/2022 - 01/2018
3Sjogren's Syndrome (Sjogren Syndrome)
01/2022 - 01/2015
3Fibrosis (Cirrhosis)
11/2021 - 01/2014
3Synovitis
04/2021 - 09/2020
3Neurocognitive Disorders (Clerambault Syndrome)
01/2021 - 01/2018
3Proteinuria
01/2021 - 01/2013
3Polymyositis
11/2020 - 01/2019
3Headache (Headaches)
10/2019 - 08/2013
2Necrosis
11/2022 - 08/2021
2Opioid-Related Disorders (Opiate Addiction)
08/2022 - 06/2020
2Autoimmune Pancreatitis
06/2022 - 07/2021
2Axial Spondyloarthritis
03/2022 - 01/2020
2Psoriatic Arthritis
01/2022 - 01/2019
2Hypertension (High Blood Pressure)
01/2022 - 01/2014

Drug/Important Bio-Agent (IBA)

21Immunoglobulin G (IgG)IBA
06/2022 - 05/2014
20AntibodiesIBA
09/2022 - 03/2012
15GlucocorticoidsIBA
06/2022 - 09/2011
15C-Reactive ProteinIBA
01/2022 - 06/2014
14Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 09/2011
14AutoantibodiesIBA
05/2022 - 03/2011
14Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2015
9Biological ProductsIBA
11/2022 - 03/2013
9Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2009
8CytokinesIBA
03/2021 - 12/2009
8Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 01/2014
6Antiphospholipid AntibodiesIBA
11/2022 - 01/2018
6EnzymesIBA
10/2021 - 09/2010
5Biosimilar PharmaceuticalsIBA
10/2022 - 01/2020
5Methamphetamine (Desoxyn)FDA LinkGeneric
05/2022 - 01/2018
5Immunoglobulin A (IgA)IBA
01/2022 - 01/2020
5tofacitinibIBA
01/2021 - 10/2019
5Rheumatoid FactorIBA
01/2020 - 08/2014
4beta-cyclodextrin tetradecasulfate (CTDS)IBA
11/2022 - 01/2019
4Janus Kinase InhibitorsIBA
11/2022 - 01/2020
4Antirheumatic Agents (DMARD)IBA
11/2022 - 01/2015
4Rituximab (Mabthera)FDA Link
10/2022 - 09/2011
4Adalimumab (Humira)FDA Link
05/2022 - 01/2020
4CreatinineIBA
05/2022 - 12/2009
4Complement System Proteins (Complement)IBA
03/2022 - 01/2021
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 11/2019
4MicroRNAs (MicroRNA)IBA
11/2021 - 03/2013
4Uric Acid (Urate)IBA
11/2021 - 03/2016
4Phospholipids (Phosphatides)FDA LinkGeneric
08/2021 - 07/2015
4Immunoglobulin E (IgE)IBA
01/2021 - 01/2020
4AutoantigensIBA
01/2021 - 02/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2020 - 10/2007
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2022 - 11/2021
3Interleukin-17 (Interleukin 17)IBA
11/2022 - 01/2013
3upadacitinibIBA
11/2022 - 12/2020
3Immunoglobulin M (IgM)IBA
05/2022 - 01/2021
3Pharmaceutical PreparationsIBA
05/2022 - 03/2016
3HLA-B27 Antigen (HLA B27 Antigen)IBA
03/2022 - 01/2020
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 01/2019
3Tacrolimus (Prograf)FDA LinkGeneric
01/2022 - 01/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2013
3Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2020
3Indicators and Reagents (Reagents)IBA
11/2021 - 12/2019
3Immunoglobulins (Immunoglobulin)IBA
11/2020 - 01/2020
3SteroidsIBA
01/2020 - 01/2017
3InterferonsIBA
01/2020 - 01/2019
3AntigensIBA
12/2019 - 05/2012
37-(N-(3-aminopropyl)amino)heptan-2-oneIBA
11/2019 - 01/2014
3cyclic citrullinated peptideIBA
06/2014 - 07/2003
2Methotrexate (Mexate)FDA LinkGeneric
10/2022 - 09/2020
2Nucleosomes (Nucleosome)IBA
09/2022 - 11/2020
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2022 - 01/2022
2Prostaglandins AIBA
04/2022 - 05/2021
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2017
2baricitinibIBA
01/2022 - 12/2020

Therapy/Procedure

29Therapeutics
10/2022 - 10/2007
4Transplantation
02/2015 - 05/2010
3Aftercare (After-Treatment)
06/2022 - 01/2015